Lymphoid and extralymphoid CD4 T cells that orchestrate the antiviral immune response

Expert Review of Clinical Immunology

Volumn 2, Issue 2, 2006, Pages 267-276

  Topham, David J ^a   Chapman, Timothy J ^a   Richter, Martin ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GREEN FLUORESCENT PROTEIN; LUCIFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; YELLOW FLUORESCENT PROTEIN;

ACCURACY; ANTIGEN SPECIFICITY; ANTIVIRAL ACTIVITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; MOLECULAR IMAGING; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; TRANSGENICS; VIRUS INFECTION;

EID: 33748505458     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.2.2.267     Document Type: Review

References (99)

1. +) T cell immunity. Nature Immunol. 5(11), 1143-1148 (2004).
2. + T-helper and a T-killer cell. Nature 393(6684), 474-478 (1998).
3. + T cells after acute infection. Nature Immunol. 5(9), 927-933 (2004).
4. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300(5617), 337-339 (2003).
5. + T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions. J. Exp. Med. 198(7), 1011-1021 (2003).
6. Graham MB, Braciale TJ. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J. Exp. Med. 186(12), 2063-2068 (1997).
7. Swain SL, Dutton RW, Woodland DL. T cell responses to influenza virus infection: effector and memory cells. Viral Immunol. 17(2), 197-209 (2004).
8. Roman E, Miller E, Harmsen A et al. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196(7), 957-968 (2002).
9. + T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium. J. Virol. 70(2), 1288-1291 (1996).
10. +) T-cell response. Nature Rev. Immunol. 4(8), 595-602 (2004).
11. + T-cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitro. J. Virol. 65(11), 6071-6076 (1991).
12. Morrison LA, Braciale VL, Braciale TJ. Antigen form influences induction and frequency of influenza-specific class I and class II MHC-restricted cytolytic T lymphocytes. J. Immunol. 141(2), 363-368 (1988).
13. + T lymphocyte clones. J. Immunol. 158(12), 5612-5618 (1997).
14. Jellison ER, Kim SK, Welsh RM. Cutting edge: MHC class II-restricted killing in vivo during viral infection. J. Immunol. 174(2), 614-618 (2005).
15. Graham MB, Dalton DK, Giltinan D et al. Response to influenza infection in mice with a targeted disruption in the interferon γ gene. J. Exp. Med. 178(5), 1725-1732 (1993).
16. + T cells independently of precursor frequency. Clin. Immunol. 113(1), 89-100 (2004).
17. Czerkinsky CC, Nilsson LA, Nygren H et al. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65(1-2), 109-121 (1983).
18. Helms T, Boehm BO, Asaad RJ et al. Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. J. Immunol. 164(7), 3723-3732 (2000).
19. Karulin AY, Hesse MD, Tary-Lehmann M et al. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity. J. Immunol. 164(4), 1862-1872 (2000).
20. Mosmann TR, Cherwinski H, Bond MW et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136(7), 2348-2357 (1986).
21. Wang X, Mosmann T. In vivo Priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-γ, and can subsequently differentiate into IL-4- or IFN-γ-secreting cells. J. Exp. Med. 194(8), 1069-1080 (2001).
22. Karulin AY, Hesse MD, Tary-Lehmann M et al. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity. J. Immunol. 164(4), 1862-1872 (2000).
23. Gazagne A, Claret E, Wijdenes J et al. A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines. J. Immunol. Methods 283(1-2), 91-98 (2003).
24. Gazagne A, Malkusch W, Vingert B et al. Fluorospot assay: methodological analysis. Methods Mol. Biol. 302, 289-296 (2005).
25. Sad S, Mosmann TR. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153(8), 3514-3522 (1994).
26. Yang L, Kobie JJ, Mosmann TR. CD73 and Ly-6A/E distinguish in vivo primed but uncommitted mouse CD4 T cells from type 1 or type 2 effector cells. J. Immunol. 175(10), 6458-6464 (2005).
27. + CD4 T cell responses is associated with nonprogression in HIV-1 infection. J. Immunol. 169(11), 6376-6385 (2002).
28. Divekar AA, Zaiss DM, Lee FE et al. Protein vaccines induce uncommitted IL-2-secreting human and mouse CD4 T cells, whereas infections induce more IFNγ-secreting cells. J. Immunol. (2006) (In Press)
29. Belshe RB. Current status of live attenuated influenza virus vaccine in the US. Virus Res. 103(1-2), 177 (2004).
30. Snyder JE, Bowers WJ, Livingstone AM et al. Measuring the frequency of mouse and human cytotoxic T cells by the Lysispot assay: independent regulation of cytokine secretion and short-term killing. Nature Med. 9(2), 231-235 (2003).
31. Fukuda M. Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J. Biol. Chem. 266(32), 21327-21330 (1991).
32. Peters PJ, Borst J, Oorschot V et al. Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J. Exp. Med. 173(5), 1099-1109 (1991).
33. Altman JD, Moss PAH, Goulder PJR et al. Phenotypic analysis of antigen-specific T lymphocytes [published erratum appears in Science 280(5371), 1821 (1998)]. Science 274(5284), 94-96 (1996).
34. + T cells. Science 280(5361), 227 (1998).
35. +) T cells. J. Immunol. Methods 271(1-2), 137-151 (2002).
36. +) T cells proliferating in response to influenza A antigen. J. Clin. Invest. 104(12), R63-R67 (1999).
37. Crawford F, Kozono H, White J et al. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8(6), 675-682 (1998).
38. Nepom GT. MHC multimers: expanding the clinical toolkit. Clin. Immunol. 106(1), 1-4 (2003).
39. + T-cell memory determined by clonal burst size [see comments]. Nature 369(6482), 652-654 (1994).
40. Foulds KE, Zenewicz LA, Shedlock DJ et al. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168(4), 1528-1532 (2002).
41. Abraham C, Miller J. Molecular mechanisms of IL-2 gene regulation following costimulation through LFA-1. J. Immunol. 167(9), 5193-5201 (2001).
42. Wenner CA, Szabo SJ, Murphy KM. Identification of IL-4 promoter elements conferring Th2-restricted expression during T helper cell subset development. J. Immunol. 158(2), 765-773 (1997).
43. Mohrs K, Wakil AE, Killeen N et al. A two-step process for cytokine production revealed by IL-4 dual-reporter mice. Immunity 23(4), 419-429 (2005).
44. Mayer KD, Mohrs K, Crowe SR et al. The functional heterogeneity of type 1 effector T cells in response to infection is related to the potential for IFN-γ production. J. Immunol. 174(12), 7732-7739 (2005).
45. Mohrs M, Shinkai K, Mohrs K et al. Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 15(2), 303-311 (2001).
46. Luker GD, Leib DA. Luciferase real-time bioluminescence imaging for the study of viral pathogenesis. Methods Mol. Biol. 292, 285-296 (2005).
47. Piwnica-Worms D, Schuster DP, Garbow JR. Molecular imaging of host-pathogen interactions in intact small animals. Cell Microbiol. 6(4), 319-331 (2004).
48. Rice BW, Cable MD, Nelson MB. In vivo imaging of light-emitting probes. J. Biomed. Opt. 6(4), 432-440 (2001).
49. +) T cells to the lung during influenza pneumonia. J. Immunol. 167(12), 6983-6990 (2001).
50. Ehl S, Klenerman P, Aichele P et al. A functional and kinetic comparison of antiviral effettor and memory cytotoxic T lymphocyte populations in vivo and in vitro. Eur. J. Immunol. 27(12), 3404-3413 (1997).
51. +) T cell recruitment and proliferation during influenza infection. Virology 340(2), 296-306 (2005).
52. + T cells. J. Immunol. 160(9), 4500-4507 (1998).
53. Oxenius A, Bachmann MF, Zinkernagel RM et al. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28(1), 390-400 (1998).
54. Fowell DJ, Magram J, Turck CW et al. Impaired Th2 subset development in the absence of CD4. Immunity 6(5), 559-569 (1997).
55. Restifo NP, Bacik I, Irvine KR et al. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154(9), 4414-4422 (1995).
56. Vezys V, Olson S, Lefrancois L. Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity 12(5), 505-514 (2000).
57. Enami M, Luytjes W, Krystal M et al. Introduction of site-specific mutations into the genome of influenza virus. Proc. Natl Acad. Sci. USA 87(10), 3802-3805 (1990).
58. + T cell lineage commitment. Nature Immunol. 6(8), 793-799 (2005).
59. Reinhardt RL, Khoruts A, Merica R et al. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410(6824), 101-105 (2001).
60. Sallusto F, Lenig D, Forster R et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401(6754), 708-712 (1999).
61. Unsoeld H, Pitcher H. Complex memory T-cell phenotypes revealed by coexpression of CD62L and CCR7. J. Virol. 79(7), 4510-4513 (2005).
62. + and CCR7-memory T cells do not differ in immediate effector cell function. J. Immunol. 169(2), 638-641 (2002).
63. + T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol. 166(3), 1813-1822 (2001).
64. Masopust D, Vezys V, Marzo AL et al. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291(5512), 2413-2417 (2001).
65. + memory T cells in nonlymphoid tissues express a highly activated phenotype. J. Immunol. 169(12), 6655-6658 (2002).
66. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nature Med. 10(9), 927-934 (2004).
67. Lorenz RG, Newberry RD. Isolated lymphoid follicles can function as sites for induction of mucosal immune responses. Ann NY Acad. Sci. 1029, 44-57 (2004).
68. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 272(5258), 60-66 (1996).
69. Ray SJ, Franki SN, Pierce RH et al. The collagen binding α1β1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 20(2), 167-179 (2004).
70. Wang XZ, Stepp SE, Brehm MA et al. Virus-specific CD8 T cells in peripheral tissues are more resistant to apoptosis than those in lymphoid organs. Immunity 18(5), 631-642 (2003).
71. +) T cells that persist in the lungs. J. Exp. Med. 193(8), 981-986 (2001).
72. + T cell memory. J. Immunol. 164(6), 3274-3282 (2000).
73. + T-cell memory. Nature Med. 7(8), 913-919 (2001).
74. + T cells in the lung airways retain the potential to mediate recall responses. J. Immunol. 171(7), 3338-3342 (2003).
75. Liang S, Mozdzanowska K, Palladino G et al. Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J. Immunol. 152(4), 1653-1661 (1994).
76. Guidotti LG, Rochford R, Chung J et al. Viral clearance without destruction of infected cells during acute HBV infection. Science 284(5415), 825-829 (1999).
77. Doherty PC, Christensen JP, Belz GT et al. Dissecting the host response to a γ-herpes virus. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356(1408), 581-593 (2001).
78. +) T-cell response to a persistent γ herpes virus. J. Virol. 73(5), 4279-4283 (1999).
79. + T cells. J. Exp. Med. 184(3), 863-871 (1996).
80. Bennett SR, Carbone FR, Karamalis F et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393(6684), 478-480 (1998).
81. Schoenberger SP, Toes RE, van der Voort EI et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393(6684), 480-483 (1998).
82. + T cells requires direct targeting to virus-infected epithelium. Eur. J. Immunol. 25(1), 111-116 (1995).
83. + T cells is inefficient in the absence of B cells. J. Virol. 72(1), 882-885 (1998).
84. Homann D, Tishon A, Berger DP et al. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice. J. Virol. 72(11), 9208-9216 (1998).
85. + T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159, 105-117 (1997).
86. Sarawar SR, Sangster M, Coffman RL et al. Administration of anti-IFN-γ antibody to β 2-microglobulin- deficient mice delays influenza virus clearance but does not switch the response to a T helper cell 2 phenotype. J. Immunol. 153(3), 1246-1253 (1994).
87. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nature Rev. Immunol. 3(3), 253-257 (2003).
88. Sakaguchi S, Sakaguchi N, Asano M et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155(3), 1151-1164 (1995).
89. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78(5), 2454-2459 (2004).
90. +) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40(5), 1062-1071 (2004).
91. + T cell responses. J. Exp. Med. 198(6), 889-901 (2003).
92. +) T cells. Microbes Infect. 3(11), 919-927 (2001).
93. +) regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol. 3(2), 135-142 (2002).
94. + suppressor T cells. Immunol. Rev. 182, 58-67 (2001).
95. Paust S, Lu L, McCarty N et al. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl Acad. Sci. USA 101(28), 10398-10403 (2004).
96. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nature Immunol. 6(4), 338-344 (2005).
97. + T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol. 32(5), 1282-1291 (2002).
98. +) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200(3), 331-343 (2004).
99. + T cell-mediated suppression by dendritic cells. Science 299(5609), 1033-1036 (2003).